SOCKS DAVID A (President, CEO, Treas. & Sec.) sold 1.5% of their position (18K shares) of PHATHOM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $586.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/8/2021ACC: 0001209191-21-060109
DirectorOfficer· President, CEO, Treas. & Sec.
Since Oct 2019
-18K
Net shares
Net seller
$586.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
18K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−15.47K
Price / share
$32.66
Trade value
$505.34K
% of position
1.3%
10/7/2021
1.23M→1.21M
Common Stock
Indirect
Shares
−2.53K
Price / share
$32.05
Trade value
$81.05K
% of position
0.2%
10/8/2021
1.21M→1.21M
Total
Net shares
−18K
Net value
-$586.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/7/2021 | S · Sale | −15.47K | $32.66 | $505.34K | 1.3% | 1.23M | 1.21M |
| Common Stock Indirect | 10/8/2021 | S · Sale | −2.53K | $32.05 | $81.05K | 0.2% | 1.21M | 1.21M |
| Total | −18K | -$586.40K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned409.73
Total
409.73 indirect409.73
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 409.73 | Indirect |
| Total | 409.73 | 409.73 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported